Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation Monica Sofia Ventura FerreiraMia Dahl SørensenFabian Beier Laboratory Investigation Open access 20 January 2020 Pages: 1 - 14
Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma Kunal S. PatelSameer KejriwalIsaac Yang Laboratory Investigation 24 January 2020 Pages: 15 - 24
Rationale for the advancement of PI3K pathway inhibitors for personalized chordoma therapy N. L. MichmerhuizenJ. H. OwenM. E. P. Prince Laboratory Investigation 17 February 2020 Pages: 25 - 35
The role of TP53 gain-of-function mutation in multifocal glioblastoma Lauren R. OlafsonManuri GunawardenaRobert W. Rapkins Clinical Study Open access 30 January 2020 Pages: 37 - 47
Postoperative oscillatory brain activity as an add-on prognostic marker in diffuse glioma Vera BelgersTianne NumanLinda Douw Clinical Study Open access 17 January 2020 Pages: 49 - 58
Transcortical approach for insular gliomas: a series of 253 patients Zhenye LiGen LiJian Xie Clinical Study 31 January 2020 Pages: 59 - 66
Salvage gamma knife radiosurgery for active brain metastases from small-cell lung cancer after whole-brain radiation therapy: a retrospective multi-institutional study (JLGK1701) Kiyoshi NakazakiShoji YomoMasakazu Nishigaki Clinical Study 13 January 2020 Pages: 67 - 76
Perioperative neurocognitive functions in patients with neuroepithelial intracranial tumors Stefanie BetteCorinna V. GradtkeJens Gempt Clinical Study 22 January 2020 Pages: 77 - 89
Efficacy of sequential radiation and chemotherapy in treating glioblastoma with poor performance status Elsa ParrRichard L. SleightholmChi Zhang Clinical Study 20 January 2020 Pages: 91 - 95
Perioperative fatigue in patients with diffuse glioma Stine ScheiOle SolheimLisa Millgård Sagberg Clinical Study Open access 23 January 2020 Pages: 97 - 107
Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients Bruno CarvalhoRafaela Gonçalves LopesRui Vaz Clinical Study 23 January 2020 Pages: 109 - 116
Outcomes of whole-brain radiation with simultaneous in-field boost (SIB) for the treatment of brain metastases Jim ZhongAlex D. WaldmanHui-Kuo G. Shu Clinical Study 22 January 2020 Pages: 117 - 123
Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma Edwin LokPyay SanEric T. Wong Clinical Study Open access 27 January 2020 Pages: 125 - 133
Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas Talia C. OughourlianJingwen YaoBenjamin M. Ellingson Clinical Study 24 January 2020 Pages: 135 - 145
Is the anatomical distribution of low-grade gliomas linked to regions of gliogenesis? Anne Jarstein SkjulsvikHans Kristian BøOle Solheim Clinical Study Open access 25 January 2020 Pages: 147 - 157
Implantation of carmustine wafers (Gliadel®) for high-grade glioma treatment. A 9-year nationwide retrospective study Charles ChampeauxJoconde Weller Clinical Study 23 January 2020 Pages: 159 - 169
Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma Prakash AmbadyRongwei FuEdward A. Neuwelt Clinical Study 05 February 2020 Pages: 171 - 176
Three-institution study on applicability of initial brain metastasis velocity for breast cancer brain metastasis patients undergoing stereotactic radiosurgery Masaaki YamamotoToru SerizawaBierta E. Barfod Clinical Study 27 January 2020 Pages: 177 - 184
Prospective memory and brain metastases: a relevant target for rehabilitation in post-operative patients? Estelle Guerdoux-NinotLuc BauchetGrégory Ninot Clinical Study 30 January 2020 Pages: 185 - 194
Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma Christopher L. TinkleKristen CampbellThomas E. Merchant Clinical Study 03 February 2020 Pages: 195 - 203
Provider views on perioperative steroid use for patients with newly diagnosed pediatric brain tumors Fatema MalbariKristen A. StaggersAdam S. Levy Clinical Study 05 February 2020 Pages: 205 - 212
Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study Kirsty J. Martin-McGillAnthony G. MarsonMichael D. Jenkinson Clinical Study Open access 08 February 2020 Pages: 213 - 227
Mapping distribution of brain metastases: does the primary tumor matter? T. SchroederP. BittrichS. Gellißen Clinical Study Open access 17 February 2020 Pages: 229 - 235
Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers Daisuke ItoKyoko AoyagiYoshinori Higuchi Clinical Study 05 February 2020 Pages: 237 - 246